Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00081952 · ClinicalTrials.gov registry record · Phase 1
Amino Acid Therapy for Hot Flashes in Postmenopausal Women
A Phase 1 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT00081952 is a Phase 1 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 15 participants.
The verdict
NCT00081952, a Phase 1 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety, tolerability, and effectiveness of the amino acid L-isoleucine in the treatment of hot flashes in postmenopausal women.
Interventions
- DRUG L-norleucine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2003-10 |
| Est. Completion | 2007-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00081952
The ClinicalTrials.gov registry entry for NCT00081952 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which L-norleucine is the first listed.
NCT00081952 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00081952 about?
NCT00081952 is a clinical study titled "Amino Acid Therapy for Hot Flashes in Postmenopausal Women". The purpose of this study is to determine the safety, tolerability, and effectiveness of the amino acid L-isoleucine in the treatment of hot flashes in postmenopausal women.
What is the current status of trial NCT00081952?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2003-10. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00081952?
The interventions under investigation include: L-norleucine (DRUG).
Who is sponsoring clinical trial NCT00081952?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.